Biogen Inc. buy Piper Sandler
Start price
12.07.24
/
50%
€213.00
Target price
12.07.25
€287.21
Performance (%)
-46.48%
End price
13.07.25
€114.00
Summary
This prediction ended on 13.07.25 with a price of €114.00. The BUY prediction by Piper_Sandler for Biogen Inc. performed very badly with a performance of -46.48%. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -1.450% | -1.450% | 24.174% |
| iShares Core DAX® | -2,53 % | -5,19 % | 4,91 % |
| iShares Nasdaq 100 | -0,03 % | 1,56 % | 21,79 % |
| iShares Nikkei 225® | -4,20 % | -7,55 % | 31,13 % |
| iShares S&P 500 | -0,80 % | 0,16 % | 15,78 % |
Comments by Piper_Sandler for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Piper Sandler from $335.00 to $313.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten